Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes.

@article{Bartu2018PrimarySA,
  title={Primary safety and effectiveness feasibility study after surgical aortic valve replacement with a new generation bioprosthesis: one-year outcomes.},
  author={K. Bartuś and Radoslaw Litwinowicz and M. Kuśmierczyk and Agata Bilewska and M. Bochenek and M. Stąp{\'o}r and S. Woźniak and J. R{\'o}żański and J. Sadowski and B. Kapelak},
  journal={Kardiologia polska},
  year={2018},
  volume={76 3},
  pages={
          618-624
        }
}
  • K. Bartuś, Radoslaw Litwinowicz, +7 authors B. Kapelak
  • Published 2018
  • Medicine
  • Kardiologia polska
    • BACKGROUND Structural valve deterioration (SVD) is a major obstacle to lifetime durability for bioprosthetic heart valves. A bio-prosthetic valve created with RESILIA™ tissue was designed to produce long-term resistance to SVD. AIM The objective of this study was to evaluate the safety and performance of this new class of RESILIA™ tissue aortic bio-prosthesis. METHODS A nonrandomised, prospective, multi-centre, single-arm, observational study was performed in 133 patients who underwent… CONTINUE READING
    View on PubMed
    doi.org
    16 Citations
    Background Citations
    7
    Methods Citations
    3
    Results Citations
    2

    Paper Mentions

    Interventional Clinical Trial
    Clinical Trial of the Edwards Aortic Bioprosthesis, Model 11000
    The purpose of this observational trial is to gather further clinical data to confirm the safety and performance of the Edwards Pericardial Aortic Bioprosthesis, Model 11000 in this… Expand
    ConditionsAortic Valve Disorder, Aortic Valve Insufficiency, Aortic Valve Stenosis, (+2 more)
    InterventionProcedure
    Edwards Lifesciences
    July 2011 - July 2018
    16 Citations
    Citation Type

    Citation Type

    Final 5-year outcomes following aortic valve replacement with a RESILIA™ tissue bioprosthesis
    • PDF
    Intermediate-term outcomes after aortic valve replacement with a novel RESILIATM tissue bioprosthesis.
    • 8
    Intermediate-term outcomes of aortic valve replacement using a bioprosthesis with a novel tissue.
    • 4
    Durability of bioprosthetic aortic valves in patients under the age of 60 years – rationale and design of the international INDURE registry
    • 1
    Study Design of the Prospective Non-Randomized Single-Arm Multicenter Evaluation of the Durability of Aortic Bioprosthetic Valves with RESILIA Tissue in Subjects under 65 Years Old (RESILIENCE Trial)
    • 2
    Mid-term follow-up after suture-less aortic heart valve implantation.
    • 3
    • PDF
    Clinical outcome and hemodynamic performance of St. Jude Trifecta aortic prosthesis: short-term follow-up and risk factors analysis.
    • 2
    Changing trends in aortic valve procedures over the past ten years-from mechanical prosthesis via stented bioprosthesis to TAVI procedures-analysis of 50,846 aortic valve cases based on a Polish National Cardiac Surgery Database.
    • 4
    Early results of the Resilia Inspiris aortic valve in the old age patients - a retrospective comparison with the Carpentier Edwards Magna Ease
    • PDF
    Ministernotomy or sternotomy in isolated aortic valve replacement? Early results
    • 4
    • PDF

    References

    SHOWING 1-10 OF 29 REFERENCES
    Long-Term Clinical and Echocardiographic Follow-Up of the Freestyle Stentless Aortic Bioprosthesis
    • 42
    • PDF
    Aortic valve replacement with a novel anti-calcification technology platform.
    • 7
    Survival and long-term outcomes following bioprosthetic vs mechanical aortic valve replacement in patients aged 50 to 69 years.
    • 138
    • PDF
    Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants.
    • 233
    Very long-term outcomes of the Carpentier-Edwards Perimount valve in aortic position.
    • 185
    Hemodynamic performance of the Medtronic Mosaic and Perimount Magna aortic bioprostheses: five-year results of a prospectively randomized study.
    • 72
    Long-term results of aortic valve replacement with mechanical prosthesis or carpentier-edwards perimount bioprosthesis in Japanese patients according to age.
    • 24
    • PDF
    Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantations.
    • 53
    One-year hemodynamic comparison of Perimount Magna with St Jude Epic aortic bioprostheses
    • 7
    • PDF
    Clinical outcomes and hemodynamics of the 19-mm Perimount Magna bioprosthesis in an aortic position: comparison with the 19-mm Medtronic Mosaic Ultra Valve.
    • 14